The impact of somatic and cognitive depressive symptoms on medical prognosis in patients with end-stage renal disease
Abstract
Purpose
To determine whether somatic or cognitive depressive symptoms affect hospitalization and death in patients with end-stage renal disease.
Design and Method
In an observational retrospective design, the patients (n = 190) completed the Beck Depression Inventory-II at baseline and were followed for 5 years to collect data all-cause mortality and hospitalization.
Findings
High somatic (53.7%, n = 102) and cognitive (52.1%, n = 99) depressive symptoms scores significantly associated with mortality (38% vs. 19%; hazard ratio [HR] = 2; 95% CI, 1.1–3.7; p = 0.02) and hospitalization (62.5% vs. 49.4%; HR = 1.6; 95% CI, 1.0–2.6; p = 0.03), respectively.
Practice Implications
In the context of diagnosing and intervening, awareness of depressive symptoms dimensionality is crucial.
CONFLICT OF INTERESTS
The authors declare that there are no conflicts of interests.
Open Research
DATA AVAILABILITY STATEMENT
Data that support the findings of this study are available from the corresponding author upon reasonable request.